146 related articles for article (PubMed ID: 38042390)
21. Tanshinol ameliorates CCl
Wang R; Wang J; Song F; Li S; Yuan Y
Drug Des Devel Ther; 2018; 12():1281-1292. PubMed ID: 29844659
[TBL] [Abstract][Full Text] [Related]
22. Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.
Liu C; Yuan X; Tao L; Cheng Z; Dai X; Sheng X; Xue D
BMC Complement Altern Med; 2015 Jun; 15():201. PubMed ID: 26122378
[TBL] [Abstract][Full Text] [Related]
23. Antifibrotic effects of Fraxetin on carbon tetrachloride-induced liver fibrosis by targeting NF-κB/IκBα, MAPKs and Bcl-2/Bax pathways.
Wu B; Wang R; Li S; Wang Y; Song F; Gu Y; Yuan Y
Pharmacol Rep; 2019 Jun; 71(3):409-416. PubMed ID: 31003150
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of MAPK and NF-κB signaling pathways alleviate carbon tetrachloride (CCl4)-induced liver fibrosis in Toll-like receptor 5 (TLR5) deficiency mice.
Shu M; Huang DD; Hung ZA; Hu XR; Zhang S
Biochem Biophys Res Commun; 2016 Feb; 471(1):233-9. PubMed ID: 26845355
[TBL] [Abstract][Full Text] [Related]
25. Montelukast prevents mice against carbon tetrachloride- and methionine-choline deficient diet-induced liver fibrosis: Reducing hepatic stellate cell activation and inflammation.
Pu S; Zhang J; Ren C; Zhou H; Wang Y; Wu Y; Yang S; Cao F; Zhou H
Life Sci; 2023 Jul; 325():121772. PubMed ID: 37178864
[TBL] [Abstract][Full Text] [Related]
26. [Mechanism of Fuzheng Huayu Tablets against hepatic fibrosis based on transcriptome and single-cell sequencing].
Lu HG; Peng WX; Jiang LH; Yao Q; Xie X; Lei C; Huang D; Liu JJ
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(10):2597-2606. PubMed ID: 38812160
[TBL] [Abstract][Full Text] [Related]
27. Forsythiae Fructuse water extract attenuates liver fibrosis via TLR4/MyD88/NF-κB and TGF-β/smads signaling pathways.
Hu N; Guo C; Dai X; Wang C; Gong L; Yu L; Peng C; Li Y
J Ethnopharmacol; 2020 Nov; 262():113275. PubMed ID: 32810620
[TBL] [Abstract][Full Text] [Related]
28. Cannabidiol alleviates carbon tetrachloride-induced liver fibrosis in mice by regulating NF-κB and PPAR-α pathways.
Ma R; Xie N; Shu Y; Wu Y; He P; Xiang Y; Zhou Y; Wang Y
Exp Biol Med (Maywood); 2024; 249():10141. PubMed ID: 38711461
[TBL] [Abstract][Full Text] [Related]
29. Salvianolic acid B suppresses hepatic stellate cell activation and liver fibrosis by inhibiting the NF-κB signaling pathway via miR-6499-3p/LncRNA-ROR.
Wang R; Li S; Chen P; Yue X; Wang S; Gu Y; Yuan Y
Phytomedicine; 2022 Dec; 107():154435. PubMed ID: 36155216
[TBL] [Abstract][Full Text] [Related]
30. Fuzheng Huayu Recipe Prevented and Treated CCl4-Induced Mice Liver Fibrosis through Regulating Polarization and Chemotaxis of Intrahepatic Macrophages via CCL2 and CX3CL1.
Zhang M; Liu HL; Huang K; Peng Y; Tao YY; Zhao CQ; Hu XD; Liu CH
Evid Based Complement Alternat Med; 2020; 2020():8591892. PubMed ID: 33293994
[TBL] [Abstract][Full Text] [Related]
31. Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling.
Wang Y; Wang R; Wang Y; Peng R; Wu Y; Yuan Y
Drug Des Devel Ther; 2015; 9():6303-17. PubMed ID: 26664050
[TBL] [Abstract][Full Text] [Related]
32. A polysaccharide from Codonopsis pilosula roots attenuates carbon tetrachloride-induced liver fibrosis via modulation of TLR4/NF-κB and TGF-β1/Smad3 signaling pathway.
Meng X; Kuang H; Wang Q; Zhang H; Wang D; Kang T
Int Immunopharmacol; 2023 Jun; 119():110180. PubMed ID: 37068337
[TBL] [Abstract][Full Text] [Related]
33. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
34. Shugan Huoxue Huayu Fang attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting transforming growth factor-β1/Smad signaling.
Liu L; Guo HB; Shao CP; Wang L; Xu YQ; Zhou YM
J Tradit Chin Med; 2022 Feb; 42(1):65-72. PubMed ID: 35294124
[TBL] [Abstract][Full Text] [Related]
35. Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway.
Deng YF; Xu QQ; Chen TQ; Ming JX; Wang YF; Mao LN; Zhou JJ; Sun WG; Zhou Q; Ren H; Zhang YH
Phytomedicine; 2022 Sep; 104():154241. PubMed ID: 35749827
[TBL] [Abstract][Full Text] [Related]
36. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
[TBL] [Abstract][Full Text] [Related]
37. E Se tea extract ameliorates CCl
Wang Z; Sun P; Zhao T; Cao J; Liu Y; Khan A; Zhou W; Cheng G
Phytomedicine; 2023 Jul; 115():154854. PubMed ID: 37156058
[TBL] [Abstract][Full Text] [Related]
38. Fuzheng Huayu recipe alleviates liver fibrosis via inhibiting NLRP3 inflammasome activation in macrophages.
Ping D; Qi J; Li M; Sun X; Peng Y; Liu C
J Ethnopharmacol; 2024 Jan; 318(Pt B):117001. PubMed ID: 37544346
[TBL] [Abstract][Full Text] [Related]
39. Modulation of IKKβ/NF-κB and TGF-β1/Smad via Fuzheng Huayu recipe involves in prevention of nutritional steatohepatitis and fibrosis in mice.
Wang RQ; Mi HM; Li H; Zhao SX; Jia YH; Nan YM
Iran J Basic Med Sci; 2015 Apr; 18(4):404-11. PubMed ID: 26019805
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of thymosin β4 in ameliorating liver fibrosis via the MAPK/NF-κB pathway.
Wang Z; Zhang Y; Wang Y; Mou Q; Ren T; Zhu L
J Biochem Mol Toxicol; 2023 Jul; 37(7):e23338. PubMed ID: 37211724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
